Fund image

Regeneron

Regeneron

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.

  • Use:
  • Date closing: -
  • Amount: -
  • Industry focus: Others;
  • Total budget: 500M $
  • Entity type: Venture Capital
  • Vertical focus: All
  • Website: https://www.regeneron.com/
  • Status:
    Open
  • Funding type: Equity investment;
  • Geographic focus:
  • Public/Private: Private
  • Stage focus:
  • Applicant target: Startup;

Overview

New York-based pharma Regeneron announced Monday that it is launching a $500 million venture capital fund that will invest in promising biotechnology innovation amid a renewed wave of investment activity in the biotech market.

Regeneron Pharmaceuticals will serve as the exclusive limited partner to the VC fund—called Regeneron Ventures—and commit $100 million annually over the next five years.

Founded and led by physician-scientists, their unique ability to repeatedly translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in their laboratories.

 

Last updated on 2024-09-12 17:40

Regeneron FAQ

0 questions

Featured Funds

Fund image

Mucker Capital

  • Usage: Go2Market; Scale-up;
  • Entity type: Venture Capital
  • Funding type: Equity investment;
  • Status: Open
  • Geographic focus: Canada; United States of America;
  • 0 reviews 0 questions
Fund image

Almi Invest

  • Usage: Go2Market;
  • Entity type: Venture Capital
  • Total: 340M €
  • Funding type: Equity investment;
  • Status: Open
  • Geographic focus: Sweden;
  • 0 reviews 0 questions
Fund image

Focused for business

  • Usage: Go2Market;
  • Entity type: Accelerator
  • Funding type: Crowdfunding; Equity investment; In kind; Other;
  • Status: Open
  • 0 reviews 0 questions